OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2025
(7)
2021
(7)
2023
(6)
2022
(4)
2024
(3)
2020
(2)
2015
(1)
2012
(1)
2010
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.
Not available
S-EPMC6366340
|
biostudies-literature
Cite
A Simple and Rapid UPLC-UV Method for Detecting DPD Deficiency in Patients With Cancer.
Not available
S-EPMC7359930
|
biostudies-literature
Cite
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Not available
S-EPMC4451172
|
biostudies-literature
Cite
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024.
Not available
S-EPMC11325250
|
biostudies-literature
Cite
Finding the Missing IMP Gene: Overcoming the Imipenemase IMP Gene Drop-Out in Automated Molecular Testing for Carbapenem-Resistant Bacteria Circulating in Latin America
Not available
S-EPMC12382776
|
biostudies-literature
Cite
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024.
Not available
S-EPMC12751633
|
biostudies-literature
Cite
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Not available
S-EPMC10668256
|
biostudies-literature
Cite
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Not available
S-EPMC10668259
|
biostudies-literature
Cite
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Not available
S-EPMC11890973
|
biostudies-literature
Cite
Acute Cardiac Care 2012
Not available
S-EPMC3760571
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets